About Pendulum
Pendulum is a company based in San Francisco (United States) founded in 2012 by Jim Bullard. It operates as a Direct-to-Consumer (D2C) and Subscription Services. Pendulum has raised $109.5 million across 5 funding rounds from investors including Mayo Clinic, Khosla Ventures and Fonterra. The company has 55 employees as of December 31, 2020. Pendulum offers products and services including Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster. Pendulum operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.
- Headquarter San Francisco, United States
- Employees 55 as on 31 Dec, 2020
- Founders Jim Bullard
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$109.5 M (USD)
in 5 rounds
-
Latest Funding Round
$10 M (USD), Series C
Jun 27, 2023
-
Investors
Mayo Clinic
& 7 more
-
Employee Count
55
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pendulum
Pendulum offers a comprehensive portfolio of products and services, including Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster.
Metabolism is improved through targeted probiotic strains daily.
Gut health is supported by replenishing keystone strains.
Glucose spikes and A1C levels are lowered effectively.
Antioxidants are increased to protect cells from damage.
People of Pendulum
Unlock access to complete
Unlock access to complete
Funding Insights of Pendulum
Pendulum has successfully raised a total of $109.5M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pendulum
Pendulum has secured backing from 8 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Mayo Clinic, Khosla Ventures and Fonterra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward US-based companies.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
Venture capital firm supporting AI founders through investments and community.
|
Locked | Locked | Locked |
Investor details for Pendulum
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pendulum
Investment portfolio details for Pendulum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pendulum
Detailed financials for Pendulum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pendulum Comparisons
Peer comparison for Pendulum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pendulum
Pendulum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
Detailed competitors of Pendulum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pendulum
Complete news archive for Pendulum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pendulum
Pendulum was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Pendulum is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Pendulum is a funded company, having raised a total of $109.5M across 5 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Pendulum is 55.
Pendulum is engaged in the development of next-generation probiotics aimed at improving whole-body health through gut microbiome transformation. The company operates in the healthcare and biotechnology sector, offering specialized products like Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster. Solutions are backed by scientific research from PhD doctors and scientists, with clinical efficacy demonstrated in products like Glucose Control for type 2 diabetes management. Partnerships with institutions such as the Mayo Clinic and rigorous in-house research further support their innovative approach to microbiome solutions.
Pendulum's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Pendulum offers Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster.
Pendulum has 8 investors. Key investors include Mayo Clinic, Khosla Ventures, Fonterra, Halle Berry, and Meritech Capital.